Additionally, in vivo studies established that the induction of SEMA3F expression resulted in the inhibition of the tumor growth, as well as a significant reduction in tumor lymphangiogenesis and lymph node involvement [14,18]. The gene discussed is SEMA3F; the disease is neoplasm.